Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ONC

BeOne Medicines Ltd.

Healthcare | Medical - Pharmaceuticals

No licensed closing price on file for ONC. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$0.44

BeOne Medicines Ltd. (NASDAQ: ONC) is a pharmaceutical company. Figures from SEC EDGAR; updated 2026-10-20 10:13 UTC.

What BeOne Medicines Ltd. does

The company faces complex regulatory challenges in obtaining coverage and reimbursement for its medicines from government and third-party payors in the U.S., where no uniform reimbursement policy exists across payors and the process requires extensive clinical and cost-effectiveness data on a payor-by-payor basis with no guarantee of adequate reimbursement. Recent U.S. executive orders and proposed Medicare payment models directed at reducing drug prices could materially impact the company's pricing flexibility and reimbursement rates, though implementation details remain uncertain.

Summarized from BeOne Medicines Ltd.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$0.44
Return on equity6.58%
Debt/equity0.17

Revenue, margins & earnings

FY2021: net loss $1.46B on revenue $1.18B$1.18BFY2021FY2022: net loss $2.00B on revenue $1.42B$1.42BFY2022FY2023: net loss $882M on revenue $2.46B$2.46BFY2023FY2024: net loss $645M on revenue $3.81B$3.81BFY2024FY2025 Net income: $287MFY2025 Taxes & interest: $160MFY2025 Operating expenses: $4.23BFY2025 Cost of revenue: $669M$5.34BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-15
  • 2026-10-15DirectorShare Option (Right to Buy)Option exercise-403,351—
  • 2026-10-15DirectorSale-10,361$3.63M
  • 2026-10-15DirectorSale-1,260$445.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does BeOne Medicines Ltd. do?

BeOne Medicines Ltd. is a pharmaceutical company, listed on NASDAQ as ONC.

When did ONC last file with the SEC?

BeOne Medicines Ltd.'s most recent SEC filing on record is a 8-K filed 2026-06-26. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 10:13 UTC. This page is also available as JSON at /api/data?ticker=ONC and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ONC and 5,000+ tickers.

Create a free account — keep ONC
For your agent
GET /api/data?ticker=ONC

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt